Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antipsychotic Drugs: Typical and Atypical Agents01:21

Antipsychotic Drugs: Typical and Atypical Agents

326
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
326
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

463
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
463
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

212
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
212
Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

Antipsychotic Drugs: Therapeutic Uses and Side Effects

390
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
390
Drug Therapy01:28

Drug Therapy

105
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
105
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

993
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
993

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Second-Generation Long-Acting Injectable Antipsychotics: A Comprehensive Assessment of Effectiveness, Safety, and Cost.

Neuropsychiatric disease and treatment·2026
Same author

Patterns of onset and progression of psychoses induced by psychoactive substance use.

Psychiatry research·2026
Same author

A review of functionality assessment scales in schizophrenia.

Frontiers in psychiatry·2026
Same author

Trends in Sudden Death Among Schizophrenia Inpatients.

Medicina (Kaunas, Lithuania)·2025
Same author

Correction: Rating opportunity for long-acting injectable antipsychotic initiation index (ROLIN).

Frontiers in psychiatry·2025
Same author

Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in Adults.

American journal of therapeutics·2025

Related Experiment Video

Updated: Sep 15, 2025

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.7K

The antipsychotics functional index (AFI) in schizophrenia.

Gabriel-Cristian Marinescu1, Petru Iulian Ifteni2, Andreea Teodorescu2

  • 1Dr. Marinescu G Gabriel-Cristian CMI, Pitesti, Romania.

Frontiers in Pharmacology
|July 17, 2025
PubMed
Summary

A new Antipsychotics Functional Index (AFI) ranks 29 antipsychotics for schizophrenia treatment. Long-acting injections, particularly D2 partial agonists like aripiprazole, show the most promise for improving patient functionality.

Keywords:
AFILAIantipsychoticsfunctionalityschizophrenia

More Related Videos

Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.6K
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

13.0K

Related Experiment Videos

Last Updated: Sep 15, 2025

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
05:14

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

3.7K
Development of a Virtual Reality Assessment of Everyday Living Skills
10:32

Development of a Virtual Reality Assessment of Everyday Living Skills

Published on: April 23, 2014

18.6K
Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization
12:00

Investigating the Effects of Antipsychotics and Schizotypy on the N400 Using Event-Related Potentials and Semantic Categorization

Published on: November 19, 2014

13.0K

Area of Science:

  • Psychiatry
  • Pharmacology
  • Neuroscience

Background:

  • Schizophrenia significantly impairs patient functionality.
  • Current antipsychotics vary in their ability to restore functionality.
  • A comparative tool is needed to guide treatment selection.

Purpose of the Study:

  • To propose a theoretical index, the Antipsychotics Functional Index (AFI), for predicting antipsychotic efficacy in improving schizophrenia patient functionality.
  • To compare 29 first- and second-generation antipsychotics based on factors influencing functional outcomes.

Main Methods:

  • Developed the Antipsychotics Functional Index (AFI) by integrating pharmacodynamics, pharmacokinetics, formulation, administration ease, and safety.
  • Ranked 29 antipsychotics using the AFI, prioritizing D2 partial agonism and less frequent administration.

Main Results:

  • The AFI identified aripiprazole long-acting injection (LAI) as the top-ranked antipsychotic due to its D2 partial agonist mechanism and flexible dosing (1-2 months).
  • Paliperidone LAI, administered every 6 months, ranked highly due to its infrequent dosing schedule.
  • Second-generation LAI antipsychotics generally scored highest for improving functionality.

Conclusions:

  • The AFI provides a framework for selecting antipsychotics to maximize patient functionality in schizophrenia.
  • D2 partial agonism and long-acting injectable formulations are key pharmacodynamic and administration advantages.
  • This index can aid psychiatrists in personalized treatment decisions for schizophrenia patients.